Results 181 to 190 of about 82,926 (310)

Neuropeptide Alterations in Type 2 Diabetes Mellitus: A Meta‐Analysis of Circulating Spexin and Galanin Levels

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
This systematic review and meta‐analysis demonstrates that circulating spexin levels are significantly reduced, whereas galanin levels are significantly elevated, in patients with type 2 diabetes mellitus. Despite their potential as biomarkers of metabolic dysregulation, the current evidence remains of very low certainty. ABSTRACT Background Spexin and
Roshan Kumar Mahat   +4 more
wiley   +1 more source

Heavy moms, wheezy kids: how maternal obesity harms breathing in offspring. [PDF]

open access: yesAm J Respir Cell Mol Biol
Williams KR, Fryer AD, Jacoby DB, Nie Z.
europepmc   +1 more source

The Effect of Polycystic Ovarian Syndrome on Development of Diabetes Mellitus by a Multistate Modelling Approach

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
PCOS was associated with a 23% higher risk of progression from normoglycemia → pre‐diabetes. PCOS was not significantly associated with direct progression of normoglycemia → DM or pre‐DM → DM. ABSTRACT Background Women with polycystic ovary syndrome (PCOS) are more susceptible to metabolic dysfunction, especially glucose impairment.
Maryam Mousavi   +4 more
wiley   +1 more source

Editorial: Diabetes and depression

open access: yesFrontiers in Clinical Diabetes and Healthcare, 2023
G. R. Sridhar, G. Lakshmi
doaj   +1 more source

Global Research Landscape on Leptin Resistance and Obesity‐Related Metabolic Dysfunction: Trends, Networks and Visualisation Analysis (1995–2025)

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Analysis of 2162 Scopus publications showed that research on leptin resistance and obesity‐related metabolic dysfunction expanded markedly from 1995 to 2025, peaking in 2014 before stabilising. The field broadened towards inflammatory, cardiometabolic and mechanistic topics, while international collaboration remained concentrated among high‐output ...
Sa'ed. H. Zyoud
wiley   +1 more source

Kiwifruit Seed Polyphenols Ameliorate High‐Fat‐Induced Obese Mice via Inhibition of Inflammation and Regulation of Gut Microbiota Balance

open access: yesFood Frontiers, Volume 7, Issue 5, September 2026.
Kiwifruit seed polyphenols (KSP) alleviate high‐fat diet‐induced obesity and metabolic dysfunction in mice by reducing body weight gain, adiposity, hepatic steatosis, and insulin resistance. KSP also suppresses inflammation, improves lipid metabolism, and reshapes gut microbiota composition, restoring short‐chain fatty acid production, thereby ...
Qingqing Liu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy